RA Medical Systems Inc. (NYSE: RMED) Starts Presentation at 9th Annual LD Micro Invitational
RA Medical Systems (NYSE: RMED) commercializes excimer lasers and catheters for the treatment of dermatological and vascular diseases. In May 2017, DABRA laser system and disposable DABRA catheter received FDA 510(k) clearance in the U.S. for the intended use of ablating a channel in occlusive peripheral vascular disease. Pharos excimer laser system is FDA-cleared and is used as a tool in the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma. DABRA and Pharos are both based on RaMedical’s core excimer laser technology platform and deploy similar mechanisms of action. For more information, visit the company's website at www.ramed.com. About NetworkNewsWire…







